Fluoxetine attenuates thermal hyperalgesia through 5-HT 1/2 receptors in streptozotocin-induced diabetic mice

European Journal of Pharmacology

Volumn 497, Issue 3, 2004, Pages 285-292

  Anjaneyulu, Muragundla ^a   Chopra, Kanwaljit ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Antidepressant; Fluoxetine; Hot plate; Neuropathic pain; Streptozotocin; Tail immersion

Indexed keywords

FLUOXETINE; ONDANSETRON; PINDOLOL; RITANSERIN; SEROTONIN 1 RECEPTOR; SEROTONIN 2 RECEPTOR; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG POTENTIATION; HOT PLATE TEST; HYPERALGESIA; INJECTION SITE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; TAIL; THERMAL STIMULATION;

ANALGESICS; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOXETINE; HEAT; HYPERALGESIA; MALE; MICE; ONDANSETRON; PINDOLOL; RECEPTORS, SEROTONIN, 5-HT1; RECEPTORS, SEROTONIN, 5-HT2; RITANSERIN; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; STREPTOZOCIN; TIME FACTORS; TOUCH;

EID: 4444249556     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.06.063     Document Type: Article

References (51)

1. A. Adell, and G. Artigas Differential effect of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study Naunyn-Schmiedeberg's Arch. Pharmacol. 343 1991 237 244
2. G.K. Aghajanian Feedback regulation of central mono-aminergic neurons: evidence for single cell recording studies M.B.H. Youdin W. Lovenberg D.F. Sharman J.R. Lagnado Essays in Neurochemistry and Neuropharmacology 1978 Wiley New York, NY 1 33
3. M. Anjaneyulu, and K. Chopra Quercetin, a bioflavonoid, attenuates thermal hyperalgesia in a mouse model of diabetic neuropathic pain Prog. Neuro-psychopharmacol. Biol. Psychiatry 27 2003 1001 1005
4. M. Anjaneyulu, and P. Ramarao Studies on gastrointestinal tract functional changes in diabetic animals Methods Find. Exp. Clin. Pharmacol. 2 2002 71 75
5. D. Ardid, A. Alloui, G. Brousse, D. Jourdan, P. Picard, C. Dubray, and A. Eschalier Potentiation of the antinociceptive effect of clomipramine by a 5-HT (1A) receptor antagonist in neuropathic pain in rats Br. J. Pharmacol. 13 2001 1118 1126
6. M. Banisinath, K. Ramabadran, H. Turndorf, and M.M. Puig Effects of acute and chronic hyperglycemia on morphine-induced inhibition of gastrointestinal transit in mice Pharmacology 37 1988 281 285
7. L. Bardin, J. Schmidt, A. Alloui, and A. Eschalier Effect of intrathecal administration of serotonin in chronic models in rats Eur. J. Pharmacol. 409 2000 37 43
8. L.L. Bellush, and S.G. Reid Altered behaviour and neurochemistry during short-term insulin withdrawal in streptozotocin-induced diabetic rats Diabetes 40 1991 217 222
9. M. Bitar, M. Koulu, S.I. Rapoport, and M. Linnoka Diabetes induced alteration in brain monoamine metabolism in rats J. Pharmacol. Exp. Ther. 236 1985 432 437
10. B. Bjorvatin, C.A. Fornal, F.J. Martin, C.W. Metzler, A. Mendlin, and B.L. Jacobs The 5-HT1A receptor antagonist p-MIPPI blocks 5-HT1A autoreceptors and increases dorsal raphe unit activity in awake cats Eur. J. Pharmacol. 356 1998 67 178
11. P. Blier, and C. De Montigny Current advances and trends in the treatment of depression Trends Pharmacol. Sci. 15 1994 220 226
12. P. Blier, C. De Montigny, and Y. Chaput A role for the serotonin state in the mechanism of action of antidepressants treatment: preclinical evidence J. Clin. Psychiatry 51 1990 14 20 (Suppl.)
13. M.J. Brown, and A.K. Asbury Diabetic neuropathy Ann. Neurol. 15 1984 2 12
14. N.A. Calcutt, and S.R. Chaplan Spinal pharmacology of tactile allodynia in diabetic rats Br. J. Pharmacol. 122 1997 1478 1482
15. P.C. Chu, M.T. Lin, and S.Y. Leu Alteration in physiological functions and in brain monoamine content in streptozotocin-diabetic rats Diabetes 35 1986 481 485
16. J.M. Clark Jr., and D.A. Lee Prevention and treatment of the complications of diabetes mellitus New Engl. J. Med. 332 1995 1210 1217
17. C. Courteix, A. Eschalier, and J. Lavarenne Streptozotocin-induced diabetic rats: behavioural evidence for a model of chronic pain Pain 53 1993 81 88
18. C. Courteix, M. Bardin, C. Chantelauze, J. Lavarenne, and A. Eschalier Study of the sensitivity of the diabetic-induced pain model in rats to range of analgesics Pain 57 1994 153 160
19. M.D.C. De Felipe, M.L. De Ceballos, and J.A. Euentes Hypoalgesia induced by antidepressants in mice: a case for opioids and serotonin Eur. J. Pharmacol. 125 1986 193 199
20. I. Dyck, S. Hansen, J. Karnes, P. O'Brien, M. Yasuda, A. Windebank, and B. Simmerman Capillary number and percentage closed in human diabetic neuronal nerve Proc. Natl. Acad. Sci. U. S. A. 82 1985 2513 2517
21. P.K. Eide, and K. Hole The role of 5-hydroxytryptamine (5-HT) receptor subtypes and plasticity in the control of nociceptive responsiveness Neuropharmacology 30 1993 727 731
22. A. Eschalier, J.L. Montastruc, J.L. Devoize, F.G. Rigal, G. aillard-Plaza, and J.C. Pechadre Influence of naloxone and mythysergide on the analgesic effect of clomipramine in rats Eur. J. Pharmacol. 74 1981 1 7
23. R.R. Filho, and R.N. Takashi Antinociceptive effects induced by desipramine and fluoxetine are dissociated from their antidepressant or anxiolytic action in mice Int. J. Neuropsychopharmacol. 2 1999 263 269
24. L.J. Forman, S.E.M. Lewis, and P. Vasilenko Streptozotocin diabetes alters immunoreactivity β-endorphin levels and pain perception after 8 weeks in female rats Diabetes 35 1986 1309 1313
25. C.A. Fornal, C.W. Metzler, R.A. Gallegos, S.C. Veasey, A.C. McCreary, and B.L. McCreary WAY-100135, a potent and selective 5-HT1A receptor antagonist, increases serotonergic neuronal activity in behaving cast: comparison with (S)-WAY-100135 J. Pharmacol. Exp. Ther. 278 1996 752 762
26. C.A. Fornal, F.J. Martin, C.W. Metzler, and B.L. Jacobs Pindolol A putative 5-hydroxytryptamine 1A antagonist dose not reverse the inhibition of serotonergic neuronal activity induced by fluoxetine in awake cats. Coparision to Way-100635 J. Pharmacol. Exp. Ther. 291 1999 220 228
27. D.A. Greene, S.A. Lattimer, and A.A. Sima Sorbitol phosphoinositol and sodium-potassium-ATPase in the pathogenesis of diabetic complications New Engl. J. Med. 316 1987 599 605
28. H. Gul, O. Yildiz, A. Dogrul, O. Yesilyurt, and A. Isimer The interaction between IL-1beta and morphine: possible mechanisms of the deficiency of the morphine-induced analgesia in diabetic mice Pain 15 2000 39 45
29. L. Hounsom, and D.R. Tomlinson Does neuropathy develop in animal models? Clin. Neurosci. 4 1997 380 389
30. D. Hoyer, D.E. Clark, J.R. Fozard, P.R. Hartig, G.R. Martin, E.J. Mylecharane, P.R. Saxena, and P.P.A. Humphrey International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin) Pharmacol. Rev. 46 1994 157 203
31. J. Hyttel Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs) Int. Clin. Psychopharmacol. 91 1994 19 26 (Suppl.)
32. J. Kamei, Y. Ohhashi, T. Aoki, and Y. Kasuya Streptozotocin-induced diabetes in mice reduces the nociceptive threshold, as recognized after application of noxious mechanical stimuli but not for thermal stimuli Pharmacol. Biochem. Behav. 39 1991 541 544
33. J. Kamei, M. Ohsawa, and H. Hitosugi Effect of diabetes on bradykinin-induced thermal hyperalgesia in mice Eur. J. Pharmacol. 390 2000 113 118
34. J. Kamei, K. Zushida, K. Morita, M. Sasakai, and S. Tanaka Role of vanilloid VR1 receptor in thermal allodynia and hyperalgesia in diabetic mice Eur. J. Pharmacol. 422 2001 83 86
35. S.A. Kannan, N.E. Saade, J.J. Haddad, A.M. Abdelnoor, S.F. Atweh, S.J. Jabbur, and B.S. Garabedian Endotoxin-induced local inflammation and hyperalgesia in rats mince, a new model for inflammatory pain Pharmacology 66 1996 373 379
36. J.H. Lee, and R.C. McCarty Glycemic control of pain threshold in diabetic and control rats Physiol. Behav. 47 1990 225 230
37. 2 receptor agonists in rats with nerve ligation Pain 90 2001 173 179
38. M. Ohsawa, and J. Kamei Passible involvement of spinal protein kinase C in thermal and allodynia and hyperalgesia in diabetic mice Eur. J. Pharmacol. 372 1999 221 228
39. V. Perez, L. Gilaberte, D. Faries, E. Alvarez, and F. Artigas Randomised double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment Lancet 349 1997 1594 1597
40. K. Ramabadran, M. Bansinath, H. Turndorf, and M.M. Puig The hyperalgesic effect of naloxone is attenuated in streptozotocin-diabetic mice Psychopharmacology (Berl.) 97 2 1989 169 174
41. K. Rasmussen, A.C. McCreary, and E.A. Shanks Attenuation of the effects of fluoxetine on serotonergic neuronal activity by pindolol in rats Neurosci. Lett. 355 2004 1 4
42. G. Said, C. Gouion-Goean, G. Stama, and G. Tchobroutsky Severe early onset polyneuropathy in insulin-dependent diabetes mellitus. A clinical and pathological study New Engl. J. Med. 19 1992 1257 1263
43. Schmidt, F.H., 1971. Methodon der harn-und blutzuckerbestrimmung: II. Handbuch Des. Diabetes Mellitus 2, 938.
44. V.P. Singh, N.K. Jain, and S.K. Kulkarni On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor Brain. Res. 915 2001 218 226
45. S. Sounvoravong, M.N. Nakashima, M. Wada, and K. Nakashima Decrease in serotonin concentration in raphe magnus nucleus and attenuation of morphine analgesia in two mice models of neuropathic pain Eur. J. Pharmacol. 484 2004 217 223
46. 1/2 receptors in both normal and diabetic mice Br. J. Pharmacol. 116 1995 3133 3138
47. M.B. Tome, M.T. Isaac, R. Harte, and C.A. Holland Randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency Int. Clin. Psychopharmacol. 12 1997 81 89
48. A.I. Vinik, M.T. Holland, J.M. LeBeau, F.J. Liuzzi, K.S. Stansberry, and L.B. Colen Diabetic neuropathies Diabetes Care 15 1992 192
49. C. Vogel, R. Mossner, M. Gerlach, T. Heinemann, D.L. Murphy, P. Riederer, K.P. Lesch, and C. Sommer Absence of thermal hyperalgesia in serotonin transporter-deficient mice J. Neurosci. 23 2003 708 715
50. J. Watkins Natural history of the diabetic neuropathy Q. J. Med. New Sciences 77 1990 1209 1218
51. Y.Q. Zhang, and G.C. Wu Endogenous descending inhibitory/facilitatory system and serotonin (5-HT) modulating spinal nociceptive transmission Sheng Li Ke Xue Jin Zhan 31 2000 211 216